Dr. Marcia Ratner & Dr. James Hendrix discuss recent developments in Alzheimer’s research.

Dr. Marcia Ratner, world-leading neurotoxicologist and research scientist at the Boston University School of Medicine. Her research focus is neurotoxicants, chemicals that can cause brain damage. Marcia is also a project manager for the Department of Pharmacology & Experimental Therapeutics at Boston University, and she also provides neurotoxicology-related consulting services resulting in major court decisions and policy change involving neurotoxicants. Dr. Ratner is also the Director of Research for Different Brains. For more information about Dr. Ratner, visit: www.neurotoxicants.com

Dr. James Hendrix is the Chief Scientific Officer at LuMind IDSC. In that role, Dr. Hendrix directs scientific initiatives for LuMind IDSC. A critical element of his role is to establish the nationwide Down Syndrome – Clinical Trial Network (DS-CTN) and to oversee the first clinical trial in the DS-CTN, the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study. The LIFE-DSR study is a natural history study focused on adults 25 years of age and older at high risk for Alzheimer’s disease. Dr. Hendrix is also focused on building potential collaborations with industry, academic and government scientists focused on Down syndrome research to maximize LuMind IDSC’s scientific impact. Prior to joining LuMind, Dr. Hendrix was Director of Global Science Initiatives, at the Alzheimer’s Association. For more about Dr. Hendrix and LuMind: https://www.lumindidsc.org/

https://twitter.com/diffbrains

https://www.facebook.com/different.brains/

https://www.instagram.com/diffbrains/

Check out more episodes of Exploring Different Brains!

http://differentbrains.org/category/edb/